Atara Biotherap (ATRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -212,480 | -140,585 | -66,257 | -230,699 | -150,687 |
| Depreciation Amortization | 3,997 | 2,568 | 1,190 | 1,847 | 915 |
| Accounts payable and accrued liabilities | 1,527 | 2,649 | 2,672 | -1,958 | 116 |
| Other Working Capital | -9,823 | -14,980 | -17,750 | 15,003 | 2,912 |
| Other Operating Activity | 39,843 | 25,559 | 9,945 | 36,035 | 24,391 |
| Operating Cash Flow | $-176,936 | $-124,789 | $-70,200 | $-179,772 | $-122,353 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 62,192 | 119,287 | -7,427 | -160,364 | -210,601 |
| PPE Investments | -2,860 | -1,438 | 75,023 | -35,925 | -31,756 |
| Investing Cash Flow | $59,332 | $117,849 | $67,596 | $-196,289 | $-242,357 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -345 | -235 | -98 | -528 | -396 |
| Common Stock Issued | 158,377 | 12,306 | 2,747 | 365,567 | 359,404 |
| Other Financing Activity | -6,695 | -6,670 | -4,575 | -7,503 | -7,493 |
| Financing Cash Flow | $151,337 | $5,401 | $-1,926 | $357,536 | $351,515 |
| Beginning Cash Position | 62,092 | 62,092 | 62,092 | 80,617 | 80,617 |
| End Cash Position | 95,825 | 60,553 | 57,562 | 62,092 | 67,422 |
| Net Cash Flow | $33,733 | $-1,539 | $-4,530 | $-18,525 | $-13,195 |
| Free Cash Flow | |||||
| Operating Cash Flow | -176,936 | -124,789 | -70,200 | -179,772 | -122,353 |
| Capital Expenditure | -3,021 | -1,534 | -796 | -35,925 | -31,756 |
| Free Cash Flow | -179,957 | -126,323 | -70,996 | -215,697 | -154,109 |